World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
58
Citations
9643
World Ranking
13412
National Ranking
410

Overview

Lihong Ye is a researcher affiliated with Nankai University in China, with a multidisciplinary focus spanning biochemistry, genetics, molecular biology, medicine, and chemistry. Their research output encompasses 24 publications in the broad area of Biochemistry, Genetics, and Molecular Biology, alongside 15 publications related to Medicine and 14 in Chemistry, indicating a diverse scientific portfolio.

Their work frequently addresses significant subfields such as molecular biology, analytical chemistry, spectroscopy, cancer research, and oncology. This emphasizes a strong interest in both fundamental biological processes and applied biomedical sciences.

The central research themes include:

  • Analytical Chemistry and Chromatography
  • Analytical chemistry methods development
  • Cancer-related molecular mechanisms research
  • Dye analysis and toxicity
  • RNA modifications and cancer
  • Cancer, lipids, and metabolism
  • Ferroptosis and cancer prognosis

Lihong Ye has contributed to a number of academic papers, with recent publications including:

  • "Sorafenib triggers ferroptosis via inhibition of HBXIP/SCD axis in hepatocellular carcinoma" (2022), published in Acta Pharmacologica Sinica
  • "The regulation of acetylation and stability of HMGA2 via the HBXIP-activated Akt-PCAF pathway in promotion of esophageal squamous cell carcinoma growth" (2020), published in Nucleic Acids Research
  • "Recent developments and applications in the microextraction and separation technology of harmful substances in a complex matrix" (2022), published in Microchemical Journal
  • "The identify role and molecular mechanism of the MALAT1/hsa-mir-20b-5p/TXNIP axis in liver inflammation caused by CHB in patients with chronic HBV infection complicated with NAFLD" (2021), published in Virus Research
  • "The modulation of PD-L1 induced by the oncogenic HBXIP for breast cancer growth" (2021), published in Acta Pharmacologica Sinica

The most frequent publication venues for their work are:

  • Acta Pharmacologica Sinica
  • Microchemical Journal
  • Food Chemistry
  • Nucleic Acids Research
  • Virus Research

Lihong Ye has collaborated extensively with several coauthors, including:

  • Jun Cao (9 collaborations)
  • Xueli Fu (6 collaborations)
  • Feifei Xu (5 collaborations)
  • Xu-he Shi (4 collaborations)
  • Kai Ye (4 collaborations)

Overall, Lihong Ye's research intersects molecular mechanisms underlying cancer progression, advanced analytical chemistry methodologies, and biochemical pathways related to disease states. Their contributions to oncology and analytical sciences are reflected through a steady output of research articles and frequent partnerships with other scientists in related fields.

Best Publications

  • Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model.

    Ling Qiao;Zhili Xu;Tiejun Zhao;Zhigang Zhao

  • Long Noncoding RNA HULC Modulates Abnormal Lipid Metabolism in Hepatoma Cells through an miR-9–Mediated RXRA Signaling Pathway

    Ming Cui;Zelin Xiao;Yue Wang;Minying Zheng

  • HBXIP-elevated methyltransferase METTL3 promotes the progression of breast cancer via inhibiting tumor suppressor let-7g.

    Xiaoli Cai;Xiao Wang;Can Cao;Yuen Gao

  • Elevation of Highly Up-regulated in Liver Cancer (HULC) by Hepatitis B Virus X Protein Promotes Hepatoma Cell Proliferation via Down-regulating p18

    Yumei Du;Guangyao Kong;Xiaona You;Shuai Zhang

  • Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signalling.

    Ling Qiao;Zhi-li Xu;Tie-jun Zhao;Li-hong Ye

  • Modulatory Role of Drebrin on the Cytoskeleton within Dendritic Spines in the Rat Cerebral Cortex

    Kensuke Hayashi;Ryoki Ishikawa;Li-Hong Ye;Xiao-Ling He

  • MicroRNA-145 Modulates N6-Methyladenosine Levels by Targeting the 3'-Untranslated mRNA Region of the N6-Methyladenosine Binding YTH Domain Family 2 Protein.

    Zhe Yang;Jiong Li;Guoxing Feng;Shan Gao

  • Effects of hepatitis B virus X protein on the development of liver cancer

    Xiaodong Zhang;Hang Zhang;Lihong Ye

  • Upregulated MicroRNA-29a by Hepatitis B Virus X Protein Enhances Hepatoma Cell Migration by Targeting PTEN in Cell Culture Model

    Guangyao Kong;Junping Zhang;Shuai Zhang;Changliang Shan

  • Long non-coding RNA HULC promotes tumor angiogenesis in liver cancer by up-regulating sphingosine kinase 1 (SPHK1).

    Zhanping Lu;Zelin Xiao;Fabao Liu;Ming Cui

  • Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells.

    Tao Zhang;Junping Zhang;Xiaona You;Qian Liu

  • The long noncoding RNA HULC promotes liver cancer by increasing the expression of the HMGA2 oncogene via sequestration of the microRNA-186

    Yuan Wang;Fuquan Chen;Man Zhao;Zhe Yang

  • MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK)

    S Zhang;C Shan;G Kong;Y Du

  • MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA.

    Ming Cui;Yue Wang;Baodi Sun;Zelin Xiao

  • HBXIP and LSD1 Scaffolded by lncRNA Hotair Mediate Transcriptional Activation by c-Myc

    Yinghui Li;Zhen Wang;Hui Shi;Hang Li

  • miR-520b Regulates Migration of Breast Cancer Cells by Targeting Hepatitis B X-interacting Protein and Interleukin-8

    Nan Hu;Jianli Zhang;Wenjing Cui;Guangyao Kong

  • A Long Noncoding RNA Perturbs the Circadian Rhythm of Hepatoma Cells to Facilitate Hepatocarcinogenesis

    Ming Cui;Minying Zheng;Baodi Sun;Yue Wang

  • Hepatitis B virus X protein inhibits tumor suppressor miR-205 through inducing hypermethylation of miR-205 promoter to enhance carcinogenesis.

    Tao Zhang;Junping Zhang;Ming Cui;Fabao Liu

  • Hepatitis B virus X protein upregulates survivin expression in hepatoma tissues

    Xiaodong Zhang;Nan Dong;Lihui Yin;Na Cai

  • MicroRNA-520b inhibits growth of hepatoma cells by targeting MEKK2 and cyclin D1.

    Weiying Zhang;Guangyao Kong;Junping Zhang;Tao Wang

Frequent Co-Authors

Takeshi Tanaka
Takeshi Tanaka Texas Medical Center
Zhimou Yang
Zhimou Yang Nankai University
Xiaodan Zhang
Xiaodan Zhang Nankai University
Jianjun Li
Jianjun Li Chinese Academy of Sciences
Kuniaki Takata
Kuniaki Takata Gunma University
Robert Chunhua Zhao
Robert Chunhua Zhao Peking Union Medical College Hospital
Masaru Tanokura
Masaru Tanokura University of Tokyo
Rong Xiang
Rong Xiang Nankai University
Xiao Yang
Xiao Yang Shanghai Jiao Tong University
Tomoaki Shirao
Tomoaki Shirao Gunma University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Lihong Ye

Trending Scientists

Recently Published Articles